Notable Labs

Personalized combination therapies for cancer patients.

News and Press

Notable Labs and Their Mission to Provide Individualized Cancer Therapy

Labcyte • July 13, 2017

CEO Matt De Silva and his team at Notable Labs reveal the story behind their mission to provide individualized cancer therapy using the Echo Acoustic Liquid Handling technology.

Labcyte Announces Collaboration with Notable Labs to Apply Functional Cancer Cell Screening to Help Clinicians Individualize Patient Care

Business Wire • Dec. 7, 2016

Labcyte Inc. and Notable Labs today announced a collaboration to apply the unique capabilities of Labcyte’s revolutionary Echo® acoustic liquid handling technology to screen individual cancer patients’ tumor cells.

Show all News and Press (2 more)